Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Prostatic Neoplasms 1Pain, Procedural 1Disease 1Anatomic Stage I Breast Cancer AJCC v8 1Agnosia 1

Interventions

pertuzumab 2Trastuzumab 2Taxes 2Paclitaxel 2High-Energy Shock Waves 2Docetaxel 2Biopsy 2trastuzumab biosimilar HLX02 1pembrolizumab 1Watchful Waiting 1Transcutaneous Electric Nerve Stimulation 1Standard of Care 1Specimen Handling 1Radiation Dose Hypofractionation 1Practice Guidelines as Topic 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Minoxidil 1Methods 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Educational Status 1Early Intervention, Educational 1Disulfides 1Carboplatin 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage I Breast Cancer AJCC v8 × Transcutaneous Electric Nerve Stimulation × 30 days × Clear all
NCT05368428 2026-05-18

Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

Emory University

Phase NA Terminated
17 enrolled
BreastOther

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡